MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
30.31
-0.33 (-1.08%)
At close: Apr 28, 2026, 4:00 PM EDT
30.31
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:01 PM EDT
MapLight Therapeutics Employees
MapLight Therapeutics had 133 employees as of December 31, 2025. The number of employees increased by 70 or 111.11% compared to the previous year.
Employees
133
Change
70
Growth
111.11%
Revenue / Employee
n/a
Profits / Employee
-$1,211,669
Market Cap
1.33B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 133 | 70 | 111.11% |
| Dec 31, 2023 | 63 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| AbCellera Biologics | 562 |
| Wave Life Sciences | 317 |
| Viridian Therapeutics | 252 |
| Olema Pharmaceuticals | 131 |
| MoonLake Immunotherapeutics | 130 |
| ArriVent BioPharma | 77 |
| GH Research | 73 |
MPLT News
- 20 days ago - MapLight's Psychosis Drug Could Deliver Billion-Dollar Upside, Says Analyst - Benzinga
- 4 weeks ago - MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - MapLight Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026 - GlobeNewsWire
- 4 months ago - MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer's Disease Psychosis - GlobeNewsWire
- 4 months ago - SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies - GlobeNewsWire
- 5 months ago - MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress - GlobeNewsWire
- 6 months ago - MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire